Unaudited Financial Results of the quarter ended 31.12.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Veerhealth Care Ltd reported standalone unaudited Q3 FY26 results with revenue from operations at approximately Rs. 389.89 lakhs, down sharply from about Rs. 725.79 lakhs in the same quarter last year — a roughly 46% YoY decline. Q3 profit after tax came in at around Rs. 7.05 lakhs versus Rs. 40.48 lakhs in Q3 FY25, an ~83% drop. Despite the weak quarter, the nine-month picture remains strong: revenue grew about 42% YoY to Rs. 1,572.30 lakhs and PAT rose roughly 79% to Rs. 89.75 lakhs. The statutory auditor issued an unqualified limited review report with no adverse observations.
The sharp quarter-on-quarter and YoY revenue and earnings decline in Q3 may concern investors even though YTD growth looks healthy. Watch for clarification on whether the Q3 softness is due to order timing or one-off issues, as the mixed picture could weigh on the stock sentiment.